Boothbay Fund Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$993K Buy
+4,700
New +$1.01M 0.01% 955
2025
Q4
Sell
-70,900
Closed -$11.1M 2004
2025
Q3
$11.1M Buy
70,900
+4,900
+7% +$757K 0.16% 141
2025
Q2
$11.1M Sell
66,000
-90,700
-58% -$13.5M 0.22% 105
2025
Q1
$21.6M Buy
156,700
+76,200
+95% +$9.71M 0.57% 19
2024
Q4
$9.52M Buy
+80,500
New +$9.4M 0.23% 107
2023
Q2
Sell
-45,800
Closed -$3.46M 1861
2023
Q1
$3.46M Buy
+45,800
New +$3.46M 0.07% 418

Other funds holding CAH

Boothbay Fund Management's CAH Position: Q1 2026 in Review

Boothbay Fund Management increased its Cardinal Health (CAH) stake by 202% in Q1 2026, buying an estimated $881K and bringing the position to 6,119 shares worth $1.29M. The position accounts for 0.02% of the portfolio, ranked #812.

Boothbay Fund Management first reported a position in CAH in Q2 2015 and has held it in 13 quarters since. The position peaked at $21.8M in Q1 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Boothbay Fund Management held 6,119 shares of Cardinal Health worth $1.29M as of Q1 2026.
  • Boothbay Fund Management bought 4,092 Cardinal Health shares in Q1 2026, an estimated $881K.
  • Cardinal Health made up 0.02% of Boothbay Fund Management's portfolio in Q1 2026, its #812 holding.
  • Boothbay Fund Management first reported a position in Cardinal Health in Q2 2015 and has held it in 13 quarters since.
  • Boothbay Fund Management's Cardinal Health position peaked at $21.8M in Q1 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.